[Federal Register Volume 76, Number 204 (Friday, October 21, 2011)]
[Notices]
[Pages 65517-65518]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-27294]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA R13 Conference Grant Review.
    Date: November 1, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Minna Liang, PhD, Scientific Review Officer, 
Grants Review Branch, Office of Extramural Affairs, National 
Institute on Drug Abuse, NIH, 6001 Executive Blvd., Room 4226, MSC 
9550, Bethesda, MD 20892-9550, 301-435-1432, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing

[[Page 65518]]

limitations imposed by the review and funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Research Education Program for Clinical Researchers 
and Clinicians.
    Date: November 1, 2011.
    Time: 11 a.m. to 2 p.m.
    Agenda To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, PhD, Chief, Grants Review 
Branch and Contracts Review Branch, Office of Extramural Affairs, 
National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., 
Room 4238, MSC 9550, Bethesda, MD 20892-9550, 301-402-6626, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, B/START Review Committee.
    Date: November 4, 2011.
    Time: 8 a.m. to 8 p.m.
    Agenda To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Mark Swieter, PhD, Chief, Extramural Activities 
Branch, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4235, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-435-1389, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, HIV/AIDS Implementation Science Targeting Drug Using 
Populations: PEPFAR (R01).
    Date: November 15, 2011.
    Time: 9 a.m. to 5:30 p.m.
    Agenda To review and evaluate grant applications.
    Place: Hilton Garden Inn--Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Nadine Rogers, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-2105, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Remote Monitoring System for Cocaine Ingestion.
    Date: November 17, 2011.
    Time: 10 a.m. to 1 p.m.
    Agenda To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, PhD, Chief, Grants Review 
Branch and Contracts Review Branch, Office of Extramural Affairs, 
National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., 
Room 4238, MSC 9550, Bethesda, MD 20892-9550, 301-402-6626, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, DIDARP Review.
    Date: December 13, 2011.
    Time: 9 a.m. to 5 p.m.
    Agenda To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Nadine Rogers, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-2105, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: October 17, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-27294 Filed 10-20-11; 8:45 am]
BILLING CODE 4140-01-P